Albemarle - ALB Stock Forecast, Price & News

18 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Albemarle in the last twelve months. There are currently 2 sell ratings, 7 hold ratings and 9 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "hold" ALB shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in ALB, but not buy additional shares or sell existing shares.
View ALB analyst ratings or view top-rated stocks.

18 analysts have issued 12 month price targets for Albemarle's shares. Their ALB share price forecasts range from $155.00 to $497.00. On average, they anticipate the company's stock price to reach $297.26 in the next twelve months. This suggests a possible upside of 5.5% from the stock's current price.
View analysts price targets for ALB or view top-rated stocks among Wall Street analysts.

Albemarle's stock was trading at $216.86 on January 1st, 2023. Since then, ALB stock has increased by 29.9% and is now trading at $281.72.
View the best growth stocks for 2023 here.

Albemarle saw a increase in short interest in December. As of December 30th, there was short interest totaling 3,400,000 shares, an increase of 18.9% from the December 15th total of 2,860,000 shares. Based on an average daily trading volume, of 1,490,000 shares, the short-interest ratio is presently 2.3 days.
View Albemarle's Short Interest.

The company is scheduled to release its next quarterly earnings announcement on Wednesday, February 15th 2023.
View our ALB earnings forecast.

Albemarle will be holding an earnings conference call on Thursday, February 16th at 9:00 AM Eastern. Interested parties can register for or listen to the call using this link or dial in at 866-813-9403 with passcode "384178".

Albemarle Co. (NYSE:ALB) announced its quarterly earnings data on Wednesday, November, 2nd. The specialty chemicals company reported $7.50 EPS for the quarter, topping analysts' consensus estimates of $6.84 by $0.66. The specialty chemicals company had revenue of $2.09 billion for the quarter, compared to analysts' expectations of $2.21 billion. Albemarle had a net margin of 27.77% and a trailing twelve-month return on equity of 26.84%. The firm's revenue was up 151.9% compared to the same quarter last year. During the same quarter last year, the company posted $1.05 earnings per share.
Read the conference call transcript.

Albemarle announced a quarterly dividend on Monday, October 24th. Investors of record on Friday, December 16th will be given a dividend of $0.395 per share on Tuesday, January 3rd. This represents a $1.58 dividend on an annualized basis and a dividend yield of 0.56%. The ex-dividend date is Thursday, December 15th.
Read our dividend analysis for ALB.

Albemarle (NYSE:ALB) pays an annual dividend of $1.58 per share and currently has a dividend yield of 0.56%. The company has been increasing its dividend for 29 consecutive years, indicating the company has a strong committment to maintain and grow its dividend. The dividend payout ratio is 11.98%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, ALB will have a dividend payout ratio of 5.63% next year. This indicates that the company will be able to sustain or increase its dividend.
Read our dividend analysis for ALB.

Albemarle updated its FY23 earnings guidance on Monday, January, 23rd. The company provided EPS guidance of $26.00-33.00 for the period, compared to the consensus estimate of $28.23. The company issued revenue guidance of $11.30-12.90 billion, compared to the consensus revenue estimate of $10.02 billion.

63 employees have rated Albemarle Chief Executive Officer Luther C. Kissam, IV on Glassdoor.com. Luther C. Kissam, IV has an approval rating of 75% among the company's employees.

Based on aggregate information from My MarketBeat watchlists, some companies that other Albemarle investors own include Intact Financial (IFC), Constellation Software (CSU), AutoCanada (ACQ), Alimentation Couche-Tard (ATD.B), AbbVie (ABBV), Vermilion Energy (VET), Wheaton Precious Metals (WPM), NVIDIA (NVDA), Rogers Communications (RCI) and Alibaba Group (BABA).

Albemarle trades on the New York Stock Exchange (NYSE) under the ticker symbol "ALB."

Albemarle's stock is owned by a variety of institutional and retail investors. Top institutional shareholders include Baillie Gifford & Co. (2.31%), International Assets Investment Management LLC (1.20%), AEGON ASSET MANAGEMENT UK Plc (0.17%), DAVENPORT & Co LLC (0.15%), Grandfield & Dodd LLC (0.12%) and New York State Teachers Retirement System (0.11%). Insiders that own company stock include Eric Norris, J Kent Masters, John Clarence Barichivich III, Karen G Narwold, Karen G Narwold, Luther C Iv Kissam, Netha N Johnson, Raphael Goszcz Crawford and Scott Tozier.
View institutional ownership trends.

Shares of ALB stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

One share of ALB stock can currently be purchased for approximately $281.72.

Albemarle (NYSE:ALB) has a market capitalization of $33.00 billion and generates $3.33 billion in revenue each year. The specialty chemicals company earns $123.67 million in net income (profit) each year or $13.19 on an earnings per share basis.

The company employs 6,000 workers across the globe.

Albemarle's mailing address is 4250 CONGRESS STREET SUITE 900, CHARLOTTE NC, 28209. The official website for the company is www.albemarle.com. The specialty chemicals company can be reached via phone at (980) 299-5700, via email at invest@albemarle.com, or via fax at 225-388-7686.